|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.20 TWD | +0.42% |
|
+7.47% | -21.88% |
| 07-13 | EirGenix Partner Secures EMA Nod for Breast Cancer Biosimilar Vial | MT |
| 05-27 | Transcenta Secures 7 Million Yuan Milestone Payment Under EirGenix Bio-Platform Deal; Shares Fall 7% | MT |
| Market Cap | 14.6B 452M 391M 365M 335M 630M 43.02B 640M 4.28B 1.68B 21.56B 1.7B 1.66B 71.29B | P/E 2026 * |
-31.7x | P/E 2027 * | 84.6x |
|---|---|---|---|---|---|
| Enterprise Value | 13.35B 413M 358M 334M 306M 576M 39.35B 585M 3.92B 1.54B 19.72B 1.55B 1.52B 65.2B | EV / Sales 2026 * |
9.06x | EV / Sales 2027 * | 5.87x |
| Free-Float |
59.98% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.42% | ||
| 1 week | +7.47% | ||
| Current month | +7.47% | ||
| 1 month | -2.43% | ||
| 3 months | +6.28% | ||
| 6 months | -20.20% | ||
| Current year | -21.88% |
| 1 week | 44.3 |  | 48.9 |
| 1 month | 44.3 | | 50.6 |
| Current year | 40.15 | | 67.6 |
| 1 year | 40.15 | | 84.3 |
| 3 years | 40.15 | | 111 |
| 5 years | 40.15 | | 163.5 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 31/03/2013 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 02/05/2016 |
Yu Wen Liu
PRN | Corporate Officer/Principal | - | 19/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 13/06/2013 |
Ming Hsien Chen
BRD | Director/Board Member | - | 12/09/2016 |
Fu Hsiu Yin
BRD | Director/Board Member | - | 12/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | +7.47% | -22.26% | -52.51% | 452M | |
| +1.59% | +2.85% | +39.32% | +0.52% | 78.32B | |
| +2.77% | +4.78% | -0.98% | +28.10% | 51.1B | |
| -0.84% | +0.09% | +20.92% | +175.02% | 49.18B | |
| -0.13% | +7.42% | -49.33% | -50.09% | 44.71B | |
| +0.80% | +2.46% | +59.13% | -24.15% | 30.72B | |
| +1.84% | +0.87% | +53.80% | +86.83% | 24.44B | |
| +9.86% | +7.94% | +126.53% | -40.68% | 23.62B | |
| +4.29% | +9.40% | +3.95% | +230.49% | 21.05B | |
| +1.66% | -3.70% | +66.13% | +121.72% | 16.61B | |
| Average | +2.23% | +4.12% | +29.72% | +47.53% | 34.02B | |
| Weighted average by Cap. | +1.88% | +4.29% | +26.88% | +44.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 45.64M 39.48M 36.87M 33.82M 63.62M 4.34B 64.63M 433M 170M 2.18B 171M 168M 7.2B | 2.34B 72.55M 62.76M 58.61M 53.76M 101M 6.9B 103M 688M 270M 3.46B 272M 266M 11.44B |
| Net income | -458M -14.18M -12.27M -11.46M -10.51M -19.77M -1.35B -20.08M -134M -52.75M -677M -53.26M -52.09M -2.24B | 172M 5.33M 4.61M 4.3M 3.95M 7.42M 507M 7.54M 50.48M 19.81M 254M 20M 19.56M 840M |
| Net Debt | -1.25B -38.61M -33.4M -31.19M -28.61M -53.82M -3.67B -54.67M -366M -144M -1.84B -145M -142M -6.09B | -838M -25.95M -22.45M -20.96M -19.23M -36.17M -2.47B -36.74M -246M -96.53M -1.24B -97.44M -95.31M -4.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | NT$48.20 | +0.42% | 465,640 |
| 06/08/26 | NT$48.00 | -1.34% | 549,930 |
| 05/08/26 | NT$48.65 | +2.64% | 968,096 |
| 04/08/26 | NT$47.40 | +2.82% | 679,594 |
| 03/08/26 | NT$46.10 | +2.79% | 572,598 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
